Market Cap (In AUD)
40.98 Million
Revenue (In AUD)
9.32 Million
Net Income (In AUD)
-13.32 Million
Avg. Volume
2.13 Million
- Currency
- AUD
- Country
- Consumer Defensive
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.004-0.023
- PE
- -
- EPS
- -
- Beta Value
- 0.779
- ISIN
- AU000000BXN6
- CUSIP
- Q77474122
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Mr. Samuel Watson
- Employee Count
- -
- Website
- https://www.bioxyne.com
- Ipo Date
- 2000-12-13
- Details
- Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products. Its products portfolio includes Progastrim for Gut and Immune Health; Progastrim plus Vitamin C for cold symptoms; and proTract for atopic dermatitis (eczema) for infants. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
More Stocks
-
OLIV
-
1354
-
6645
-
2082ACWA POWER Company
2082
-
MDRN
-
ARM
-
WBC
-
2250